Business Description
Bavarian Nordic is a Danish biopharmaceutical company founded in 1992 and based in Hellerup, Denmark, that develops and produces vaccines protecting against serious infectious diseases. Its portfolio includes approved vaccines for smallpox, monkeypox, rabies, tick-borne encephalitis, cholera, and typhoid fever, sold under well-known brand names across more than 20 countries worldwide. The company is also advancing an experimental vaccine targeting encephalitis-causing viruses, currently in mid-stage clinical trials.
